• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 B 100 基因第 3500 位碱基缺失突变致家族性高胆固醇血症家系的基因诊断

Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR.

机构信息

Instituto Biofisika (UPV/EHU, CSIC), 48080, Bilbao, Spain.

Instituto Biofisika (UPV/EHU, CSIC) and Departamento de Bioquímica, Universidad del País Vasco, Apdo. 644, 48080, Bilbao, Spain.

出版信息

Sci Rep. 2020 Feb 3;10(1):1727. doi: 10.1038/s41598-020-58734-9.

DOI:10.1038/s41598-020-58734-9
PMID:32015373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6997160/
Abstract

The primary genetic cause of familial hypercholesterolemia (FH) is related to mutations in the LDLR gene encoding the Low-density Lipoprotein Receptor. LDLR structure is organized in 5 different domains, including an EGF-precursor homology domain that plays a pivotal role in lipoprotein release and receptor recycling. Mutations in this domain constitute 51.7% of the total missense variants described in LDLR. The aim of the present work was to analyse how clinically significant variants in the EGF-precursor homology domain impact LDLR. The activity of sixteen LDLR variants was functionally characterized by determining LDLR expression by Western blot and LDLR expression, LDL binding capacity and uptake, and LDLR recycling activity by flow cytometry in transfected CHO-ldlA7 cells. Of the analysed variants, we found six non-pathogenic LDLR variants and ten pathogenic variants distributed as follow: three class 3 variants; four class 2 variants; and three class 5 variants. These results can be incorporated into clinical management of patients by helping guide the appropriate level of treatment intensity depending on the extent of loss of LDLR activity. This data can also contribute to cascade-screening for pathogenic FH variants.

摘要

家族性高胆固醇血症(FH)的主要遗传原因与 LDLR 基因编码的低密度脂蛋白受体(LDLR)突变有关。LDLR 结构分为 5 个不同的结构域,包括 EGF 前体同源结构域,在脂蛋白释放和受体再循环中起着关键作用。该结构域的突变构成了 LDLR 中描述的总错义变异的 51.7%。本研究旨在分析 EGF 前体同源结构域中的临床显著变异如何影响 LDLR。通过 Western blot 测定 LDLR 表达,用流式细胞术测定 LDLR 表达、LDL 结合能力和摄取以及 LDLR 再循环活性,对十六种 LDLR 变体进行了功能特征分析,这些变体在转染的 CHO-ldlA7 细胞中进行。在分析的变体中,我们发现了六个非致病性 LDLR 变体和十个致病性变体,分布如下:三个 3 类变体;四个 2 类变体;三个 5 类变体。这些结果可通过帮助指导根据 LDLR 活性丧失的程度确定适当的治疗强度水平,纳入患者的临床管理。这些数据还可以为致病性 FH 变体的级联筛查做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/2561d25d8572/41598_2020_58734_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/a60109aff5f3/41598_2020_58734_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/e0d966db0615/41598_2020_58734_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/81f7608d63a7/41598_2020_58734_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/451afc2f5717/41598_2020_58734_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/2561d25d8572/41598_2020_58734_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/a60109aff5f3/41598_2020_58734_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/e0d966db0615/41598_2020_58734_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/81f7608d63a7/41598_2020_58734_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/451afc2f5717/41598_2020_58734_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dc7/6997160/2561d25d8572/41598_2020_58734_Fig5_HTML.jpg

相似文献

1
Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR.载脂蛋白 B 100 基因第 3500 位碱基缺失突变致家族性高胆固醇血症家系的基因诊断
Sci Rep. 2020 Feb 3;10(1):1727. doi: 10.1038/s41598-020-58734-9.
2
p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro.p.(Asp47Asn) 和 p.(Thr62Met):体外功能表征的非致病性 LDL 受体错义变异体。
Sci Rep. 2018 Nov 9;8(1):16614. doi: 10.1038/s41598-018-34715-x.
3
Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.位于富含半胱氨酸重复序列中的低密度脂蛋白受体错义变体的活性相关效应。
Atherosclerosis. 2015 Feb;238(2):304-12. doi: 10.1016/j.atherosclerosis.2014.12.026. Epub 2014 Dec 20.
4
Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.第 46 位半胱氨酸残基在 LDL 受体第一个富含半胱氨酸重复序列中的替换会损害载脂蛋白的识别。
PLoS One. 2018 Oct 17;13(10):e0204771. doi: 10.1371/journal.pone.0204771. eCollection 2018.
5
Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.严重受累的家族性高胆固醇血症患者中的复合杂合低密度脂蛋白受体变异体
Acta Biochim Pol. 2017;64(1):75-79. doi: 10.18388/abp.2016_1283. Epub 2016 Nov 23.
6
Functional analysis of six uncharacterised mutations in LDLR gene.LDLR 基因中六个未明确功能突变的功能分析。
Atherosclerosis. 2019 Dec;291:44-51. doi: 10.1016/j.atherosclerosis.2019.10.013. Epub 2019 Oct 12.
7
Functional characterization and classification of frequent low-density lipoprotein receptor variants.常见低密度脂蛋白受体变异体的功能特性与分类
Hum Mutat. 2015 Jan;36(1):129-41. doi: 10.1002/humu.22721. Epub 2014 Nov 27.
8
Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.系统预测低密度脂蛋白受体错义突变引起的家族性高胆固醇血症。
Atherosclerosis. 2019 Feb;281:1-8. doi: 10.1016/j.atherosclerosis.2018.12.003. Epub 2018 Dec 15.
9
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.功能性分析 LDLR(低密度脂蛋白受体)变异在患者淋巴细胞中,以评估依维莫司在杂合子家族性高胆固醇血症患者中对 LDLR 活性谱的影响。
Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2248-2260. doi: 10.1161/ATVBAHA.119.313051. Epub 2019 Oct 3.
10
Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.与家族性高胆固醇血症相关的低密度脂蛋白受体新变体的功能分析。
Hum Mutat. 2019 Aug;40(8):1181-1190. doi: 10.1002/humu.23801. Epub 2019 Jun 18.

引用本文的文献

1
Role of Next-Generation Sequencing in Diagnosis of Familial Hypercholesterolemia in Serbia.下一代测序在塞尔维亚家族性高胆固醇血症诊断中的作用
Diagnostics (Basel). 2025 May 12;15(10):1212. doi: 10.3390/diagnostics15101212.
2
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation.低密度脂蛋白受体调控的信号通路及分子机制
Circ Res. 2025 Apr 11;136(8):902-919. doi: 10.1161/CIRCRESAHA.124.323578. Epub 2025 Apr 10.
3
Regulation of lipid storage and inflammation in the liver by CEACAM1.癌胚抗原相关细胞黏附分子1(CEACAM1)对肝脏脂质储存和炎症的调节作用

本文引用的文献

1
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
2
The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia.临床、分子和功能数据的综合分析对于家族性高胆固醇血症的基因诊断至关重要。
Genet Med. 2015 Dec;17(12):980-8. doi: 10.1038/gim.2015.14. Epub 2015 Mar 5.
3
Eur J Clin Invest. 2024 Dec;54 Suppl 2(Suppl 2):e14338. doi: 10.1111/eci.14338.
4
Cellular and functional evaluation of LDLR missense variants reported in hypercholesterolemic patients demonstrates their hypomorphic impacts on trafficking and LDL internalization.对高胆固醇血症患者中报告的低密度脂蛋白受体(LDLR)错义变体进行的细胞和功能评估表明,它们对转运和LDL内化具有低表达影响。
Front Cell Dev Biol. 2024 Jul 24;12:1412236. doi: 10.3389/fcell.2024.1412236. eCollection 2024.
5
LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia.低密度脂蛋白受体(LDLR)基因c.89_92dup:家族性高胆固醇血症中的一种新型移码变异。
Lipids Health Dis. 2024 Jun 12;23(1):182. doi: 10.1186/s12944-024-02173-2.
6
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing.基于纳米孔测序的 CRISPR-Cas9 引导扩增自由基因组诊断家族性高胆固醇血症。
PLoS One. 2024 Mar 20;19(3):e0297231. doi: 10.1371/journal.pone.0297231. eCollection 2024.
7
The association between polymorphism of LDL-R gene and ischemic stroke risk in Chinese population: A meta-analysis.中国人群低密度脂蛋白受体(LDL-R)基因多态性与缺血性卒中风险的关联:一项荟萃分析。
Heliyon. 2024 Feb 12;10(4):e26314. doi: 10.1016/j.heliyon.2024.e26314. eCollection 2024 Feb 29.
8
Phenotypic homozygous familial hypercholesterolemia successfully treated with proprotein convertase subtilisin/kexin type 9 inhibitors.前蛋白转化酶枯草溶菌素/克新9型抑制剂成功治疗表型纯合子家族性高胆固醇血症
Clin Case Rep. 2024 Feb 19;12(2):e8537. doi: 10.1002/ccr3.8537. eCollection 2024 Feb.
9
iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.iPSC 衍生的内皮细胞揭示了家族性高胆固醇血症中的 LDLR 功能障碍和基因表达谱失调。
Int J Mol Sci. 2024 Jan 5;25(2):689. doi: 10.3390/ijms25020689.
10
Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.家族性高胆固醇血症中的新型低密度脂蛋白受体变异体:基于二代测序的鉴定、电子克隆特征分析及药物遗传学见解
Life (Basel). 2023 Jul 11;13(7):1542. doi: 10.3390/life13071542.
Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.
位于富含半胱氨酸重复序列中的低密度脂蛋白受体错义变体的活性相关效应。
Atherosclerosis. 2015 Feb;238(2):304-12. doi: 10.1016/j.atherosclerosis.2014.12.026. Epub 2014 Dec 20.
4
Functional characterization and classification of frequent low-density lipoprotein receptor variants.常见低密度脂蛋白受体变异体的功能特性与分类
Hum Mutat. 2015 Jan;36(1):129-41. doi: 10.1002/humu.22721. Epub 2014 Nov 27.
5
The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes.家族性高脂血症综合征的遗传结构:多个基因中的罕见突变和常见变异
Curr Opin Lipidol. 2014 Aug;25(4):274-81. doi: 10.1097/MOL.0000000000000090.
6
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro.截短型表皮生长因子A(EGF-A)肽的设计与合成,其在体外PCSK9存在的情况下可恢复低密度脂蛋白受体(LDL-R)的循环利用。
Chem Biol. 2014 Feb 20;21(2):284-94. doi: 10.1016/j.chembiol.2013.11.014. Epub 2014 Jan 16.
7
Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants.载脂蛋白 B 基因多态性与血脂及非高密度脂蛋白胆固醇的关系:一项 64 个特定载脂蛋白 B 基因序列变异体检测的 29365 例个体研究
Eur Heart J. 2012 Sep;33(18):2325-30. doi: 10.1093/eurheartj/ehs038. Epub 2012 Mar 4.
8
Functional characterization of splicing and ligand-binding domain variants in the LDL receptor.LDL 受体剪接和配体结合域变异体的功能特征。
Hum Mutat. 2012 Jan;33(1):232-43. doi: 10.1002/humu.21630. Epub 2011 Nov 3.
9
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.家族性高胆固醇血症:美国国家脂质协会家族性高胆固醇血症专家小组的患病率、遗传学、诊断及筛查建议
J Clin Lipidol. 2011 Jun;5(3 Suppl):S9-17. doi: 10.1016/j.jacl.2011.03.452. Epub 2011 Apr 3.
10
Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes.荷兰的奠基者突变:低密度脂蛋白受体和载脂蛋白B基因中最常见突变的地理分布
Neth Heart J. 2011 Apr;19(4):175-182. doi: 10.1007/s12471-011-0076-6. Epub 2011 Jan 27.